Filing Details
- Accession Number:
- 0001179110-18-007255
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-21 17:21:52
- Reporting Period:
- 2018-05-17
- Accepted Time:
- 2018-05-21 17:21:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1578845 | Allergan Plc | AGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536778 | William Meury | Clonshaugh Business And Technology Park, Coolock, Co. Dublin L2 D17 E400 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2018-05-17 | 1,467 | $68.11 | 20,369 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2018-05-17 | 19,785 | $68.11 | 40,154 | No | 4 | M | Direct | |
| Ordinary Shares, Par Value $0.0001 | Disposition | 2018-05-17 | 24,425 | $154.59 | 15,729 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Incentive Stock Option | Disposition | 2018-05-17 | 1,467 | $0.00 | 1,467 | $68.11 |
| Ordinary Shares | Non-Qualified Options to Purchase Common Stock | Disposition | 2018-05-17 | 19,785 | $0.00 | 19,785 | $68.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-12-05 | No | 4 | M | Direct | |
| 0 | 2018-12-05 | No | 4 | M | Direct |
Footnotes
- This exercise is pursuant to a previously established 10b5-1 Trading Plan dated November 16, 2017 for the Reporting Person.
- Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
- This sale is pursuant to a previously established 10b5-1 Trading Plan dated November 16, 2017 for the Reporting Person.
- The options vested on December 6, 2015.
- The options vested in five equal installments on December 6, 2011, 2012, 2013, 2014 and 2015.
Billionaire Hedge Funds
